SD BioSensor, Inc
KRX:137310.KS
9330 (KRW) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 180,118.442 | 170,605.692 | 167,460.522 | 176,389.139 | 159,610.87 | 151,028.229 | 162,637.071 | 182,400.344 | 197,385.785 | 551,164.677 | 795,007.415 | 1,388,443.563 | 443,757.289 | 526,699.145 | 780,388.141 | 1,179,116.265 | 930,941.371 | 535,904.032 | 197,302.879 |
| Cost of Revenue
| 92,724.353 | 88,516.014 | 111,985.769 | 112,460.107 | 118,041.487 | 112,265.15 | 126,938.16 | 203,495.558 | 251,050.334 | 198,435.436 | 377,217.717 | 712,303.292 | 237,923.553 | 211,130.269 | 342,449.534 | 568,426.843 | 510,583.776 | 196,642.804 | 105,436.617 |
| Gross Profit
| 87,394.089 | 82,089.678 | 55,474.754 | 63,929.032 | 41,569.383 | 38,763.079 | 35,698.911 | -21,095.214 | -53,664.549 | 352,729.241 | 417,789.699 | 676,140.271 | 205,833.736 | 315,568.876 | 437,938.607 | 610,689.422 | 420,357.595 | 339,261.227 | 91,866.262 |
| Gross Profit Ratio
| 0.485 | 0.481 | 0.331 | 0.362 | 0.26 | 0.257 | 0.22 | -0.116 | -0.272 | 0.64 | 0.526 | 0.487 | 0.464 | 0.599 | 0.561 | 0.518 | 0.452 | 0.633 | 0.466 |
| Reseach & Development Expenses
| 24,568.708 | 20,285.452 | 23,272.141 | 19,106.212 | 14,059.448 | 17,213.344 | 16,671.875 | 15,094.259 | 13,972.569 | 10,946.218 | 13,098.028 | 7,745.666 | 2,969.541 | 5,454.248 | 7,191.386 | 3,270.483 | 3,903.577 | 2,837.858 | 1,991.04 |
| General & Administrative Expenses
| 6,790.199 | 6,087.961 | 4,695.725 | 6,147.139 | 3,429.456 | 83,002.8 | 112,104.38 | 102,683.493 | 3,634.559 | 3,808.795 | 2,966.608 | 2,198.324 | 1,521.306 | 1,351.163 | 1,006.229 | 828.418 | 464.973 | 570.527 | 316.443 |
| Selling & Marketing Expenses
| 18,379.314 | 13,823.106 | 14,980.477 | 13,492.962 | 23,687.846 | 13,256.186 | 34,305.139 | 42,827.017 | 18,037.101 | 16,566.2 | 21,874.894 | 19,208.596 | 39,487.821 | 46,262.439 | 18,220.629 | 20,012.079 | 25,553.282 | 49,170.823 | 4,151.847 |
| SG&A
| 25,169.513 | 19,911.067 | 47,294.791 | 54,845.493 | 57,853.207 | 83,002.8 | 112,104.38 | 102,683.493 | 21,671.66 | 20,374.995 | 24,841.502 | 21,406.92 | 41,009.127 | 47,613.602 | 19,226.858 | 20,840.497 | 26,018.255 | 49,741.35 | 4,468.29 |
| Other Expenses
| 55,728.025 | 52,432.248 | 0 | -539.318 | 728.321 | -166,005.6 | -224,208.761 | -15,094.259 | 25,278.753 | 27,962.389 | 31,703.971 | 27,367.595 | 224.594 | -1,331.499 | -955.768 | -452.826 | -45.653 | -56.658 | 138.899 |
| Operating Expenses
| 105,466.246 | 92,628.767 | 70,358.861 | 74,491.023 | 71,184.334 | -83,002.8 | -112,104.381 | 102,683.493 | 60,922.982 | 59,283.602 | 69,643.501 | 56,520.181 | 57,970.878 | 66,056.722 | 47,587.769 | 34,374.692 | 41,956.49 | 60,878.341 | 11,107.471 |
| Operating Income
| -18,072.158 | -10,539.089 | -14,884.108 | -10,561.991 | -29,614.951 | -44,239.721 | -76,405.47 | -123,778.707 | -114,587.531 | 485,960.235 | 348,146.198 | 619,620.09 | 147,862.856 | 249,512.155 | 390,350.838 | 576,314.729 | 378,401.105 | 278,382.886 | 80,758.791 |
| Operating Income Ratio
| -0.1 | -0.062 | -0.089 | -0.06 | -0.186 | -0.293 | -0.47 | -0.679 | -0.581 | 0.882 | 0.438 | 0.446 | 0.333 | 0.474 | 0.5 | 0.489 | 0.406 | 0.519 | 0.409 |
| Total Other Income Expenses Net
| -133,825.69 | -19,114.608 | -8,805.413 | -3,465.535 | -112,268.619 | -20,732.412 | -6,251.633 | -25,322.464 | -246,437.838 | 193,999.782 | 118,788.723 | 29,113.406 | 8,175.825 | 45,472.671 | 37.798 | 17,913.402 | -26,661.521 | 2,756.864 | 984.918 |
| Income Before Tax
| -151,897.847 | -29,653.696 | -23,689.521 | -13,076.68 | -142,098.766 | -64,972.134 | -82,657.103 | -149,101.169 | -361,025.369 | 487,445.421 | 466,934.921 | 648,733.497 | 156,038.681 | 294,984.825 | 392,071.604 | 597,721.985 | 351,739.584 | 281,139.75 | 81,743.708 |
| Income Before Tax Ratio
| -0.843 | -0.174 | -0.141 | -0.074 | -0.89 | -0.43 | -0.508 | -0.817 | -1.829 | 0.884 | 0.587 | 0.467 | 0.352 | 0.56 | 0.502 | 0.507 | 0.378 | 0.525 | 0.414 |
| Income Tax Expense
| -17,637.832 | -94,839.435 | -5,701.981 | -2,862.171 | -43,267.455 | -1,162.836 | 402.891 | 73,317.521 | -34,589.228 | 65,764.452 | 128,329.524 | 173,795.04 | 26,673.764 | 77,642.697 | 111,893.351 | 160,175.125 | 37,064.109 | 49,789.484 | 8,959.892 |
| Net Income
| -133,619.533 | 65,066.279 | -18,708.443 | -11,149.2 | -98,426.699 | -64,116.756 | -82,486.83 | -222,418.69 | -326,436.141 | 421,331.503 | 340,023.076 | 474,451.484 | 130,473.637 | 251,820.709 | 287,033.65 | 440,486.11 | 315,589.732 | 226,427.176 | 71,265.005 |
| Net Income Ratio
| -0.742 | 0.381 | -0.112 | -0.063 | -0.617 | -0.425 | -0.507 | -1.219 | -1.654 | 0.764 | 0.428 | 0.342 | 0.294 | 0.478 | 0.368 | 0.374 | 0.339 | 0.423 | 0.361 |
| EPS
| -1,092.51 | 532 | -153 | -91.14 | -804.48 | -551.57 | -806.25 | -2,174.19 | -3,192.42 | 4,166.32 | 3,362 | 4,691 | 4,116.31 | 2,473 | 3,076 | 4,720 | 3,381.31 | 2,426 | 764 |
| EPS Diluted
| -1,092.51 | 532 | -152.93 | -91.14 | -804.48 | -551.57 | -806.25 | -2,174.19 | -3,192.42 | 4,166.32 | 3,362 | 4,594.22 | 3,185.78 | 2,473 | 3,064 | 4,664 | 3,381.31 | 2,426 | 764 |
| EBITDA
| -98,929.034 | 24,391.588 | 29,101.751 | 24,658.607 | -84,470.995 | -18,957.938 | -34,977.133 | -112,452.26 | -346,845.444 | 303,859.712 | 358,051.963 | 626,284.412 | 163,177.56 | 297,845.059 | 401,104.217 | 583,404.294 | 381,255.721 | 280,890.131 | 82,188.117 |
| EBITDA Ratio
| -0.549 | 0.143 | 0.174 | 0.14 | -0.529 | -0.126 | -0.215 | -0.617 | -1.757 | 0.551 | 0.45 | 0.451 | 0.368 | 0.565 | 0.514 | 0.495 | 0.41 | 0.524 | 0.417 |